{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:45:18Z","timestamp":1777445118361,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["nyaspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The possibility of chemical terrorism within the United States is a rising concern, with the eye being one of the most sensitive tissues to toxicant exposure. We sought to develop mouse models of toxicant\u2010induced ocular injury for the purpose of evaluating potential therapeutics. Chloropicrin (CP) and hydrogen fluoride (HF) were selected for the study owing to their reportedly high potential to induce ocular injury. Eyes of female BALB\/c mice were exposed to CP or HF vapor in order to produce a moderate injury, as defined by acute corneal epithelial loss followed by progressive corneal pathology with the absence of injury to deeper eye structures. Clinical injury progression was evaluated up to 12 weeks postexposure, where a significant dose\u2010dependent induction of corneal neovascularization was measured. Histopathology noted epithelial necrosis and stromal edema as early as 24 h after exposure but was resolved by 12 weeks. A significant increase in inflammatory cytokine concentrations was measured in the cornea 24 h after exposure and returned to baseline by day 14. The ocular injury models we developed here for CP and HF exposure should serve as a valuable tool for the future evaluation of novel therapeutics and the molecular mechanisms of injury.<\/jats:p>","DOI":"10.1111\/nyas.14297","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T13:56:02Z","timestamp":1579701362000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of mouse models for the study of chloropicrin and hydrogen fluoride ocular injury"],"prefix":"10.1111","volume":"1479","author":[{"given":"Robert D.","family":"Causey","sequence":"first","affiliation":[{"name":"Research Division, U.S. Army Medical Research Institute of Chemical Defense  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Koenig","sequence":"additional","affiliation":[{"name":"Research Division, U.S. Army Medical Research Institute of Chemical Defense  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Autrey","sequence":"additional","affiliation":[{"name":"U.S. Army Public Health Center  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"McGowan","sequence":"additional","affiliation":[{"name":"U.S. Army Public Health Center  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber M.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Research Division, U.S. Army Medical Research Institute of Chemical Defense  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Lehman","sequence":"additional","affiliation":[{"name":"Research Division, U.S. Army Medical Research Institute of Chemical Defense  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert L.","family":"Ruff","sequence":"additional","affiliation":[{"name":"Research Division, U.S. Army Medical Research Institute of Chemical Defense  Aberdeen Proving Ground Harford County Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"NIH CounterACT Program. Accessed August 29 2019.https:\/\/www.ninds.nih.gov\/Current-Research\/Trans-Agency-Activities\/CounterACT."},{"key":"e_1_2_8_3_1","unstructured":"Cox J.A. R.Gooding J.E.Kolakowski et\u00a0al.2012.Chemical Terrorism Risk Assessment CSAC 12\u2010006.U.S. Department of Homeland Security Science and Technology Directorate Chemical Security Analysis Center Aberdeen Proving Ground MD."},{"key":"e_1_2_8_4_1","unstructured":"Department of Pesticide Regulation (DPR).2012.Chloropicrin risk characterization document. DPR California Environmental Protection Agency. Accessed January 8 2020.http:\/\/www.cdpr.ca.gov\/docs\/risk\/rcd\/chloropicrinrisk_2012.pdf."},{"key":"e_1_2_8_5_1","volume-title":"Medical Aspects of Gas Warfare","author":"Bancroft W.D.","year":"1926"},{"key":"e_1_2_8_6_1","volume-title":"Fluorine Compounds, Inorganic. Ullmann's Encyclopedia of Industrial Chemistry","author":"Aigueperse J.","year":"2000"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2012.731666"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.2.1237"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.05.001"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000178743.06340.2c"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1188"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.9.1.9.3978"},{"key":"e_1_2_8_13_1","unstructured":"National Advisory Committee.2008.Acute exposure guideline levels: Chloropicrin. Accessed January 8 2020.https:\/\/www.epa.gov\/sites\/production\/files\/2014-08\/documents\/chloropicrin_interim_0.pdf."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2010.00140"},{"key":"e_1_2_8_15_1","first-page":"649","article-title":"Ocular hydrofluoric acid burns: animal model, mechanism of injury and therapy","volume":"88","author":"McCulley J.P.","year":"1990","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"e_1_2_8_16_1","first-page":"487","article-title":"Research on mouse model of grade II corneal alkali burn","volume":"9","author":"Bai J.Q.","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"e_1_2_8_17_1","first-page":"157","article-title":"Treatment of hydrofluoric acid exposure to the eye","volume":"8","author":"Atley K.","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32833a8da2"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx9700477"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0461(2000)14:1<26::AID-JBT4>3.0.CO;2-T"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/tcm.1770100104"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-7992(87)90055-8"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.3791\/57372"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnyas.14297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nyas.14297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/nyas.14297","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nyas.14297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T15:19:04Z","timestamp":1693840744000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/nyas.14297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/nyas.14297"],"URL":"https:\/\/doi.org\/10.1111\/nyas.14297","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"2019-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}